Trade Mark Journal No.2026/013 27 March 2026

UK00004355693 16 March 2026 (5,10)

AERVIXA

International priority date claimed: 9 February 2026 (European Union Intellectual Property Office (EUIPO)) (019314768)

Class 5: Pharmaceuticals; pharmaceutical and medical preparations; respiratory stimulants; compounds for treating respiratory diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of diseases of the respiratory system.
Class 10: Pharmaceutical and medical devices; pharmaceutical and medical instruments; surgical and medical apparatus and instruments; masks and equipment for artificial respiration.

Glenmark Pharmaceuticals s.r.o.

Representative: Boult Wade Tennant LLP